Indian Pharma - Live Stock Quotes, Stock Price Update and Analysis from Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 583.35 -0.50% 586.55 0.31%
 More Info 
AJANTA PHARMA 967.95 -0.55% 967.85 -0.66%
 More Info 
ALEMBIC PHARMA 547.20 1.49% 544.45 0.49%
 More Info 
BIOCON LTD 606.85 -1.39% 605.85 -1.53%
 More Info 
CADILA HEALTHCARE 311.55 -0.89% 311.80 -0.70%
 More Info 
CIPLA 541.35 0.18% 541.15 0.11%
 More Info 
DIVIS LABORATORIES 1,574.60 -2.71% 1,574.75 -2.87%
 More Info 
GLENMARK PHARMA 576.40 1.18% 577.10 1.36%
 More Info 
INDOCO REMEDIES 173.95 0.52% 173.10 -0.55%
 More Info 
IPCA LABS 809.45 4.45% 808.25 4.24%
 More Info 
J.B.CHEMICALS 313.05 0.76% 314.35 0.70%
 More Info 
LUPIN LTD 771.10 -0.61% 770.90 -0.50%
 More Info 
NATCO PHARMA 573.55 -3.51% 575.15 -1.99%
 More Info 
NIFTY 50 Not Listed 10,640.95 -0.78%
 More Info 
ORCHID PHARMA LTD 3.22 0.94% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 159.10 -1.09% 160.65 -0.86%
 More Info 
PIRAMAL ENTERPRISES 2,169.25 0.40% 2,176.75 0.69%
 More Info 
S&P BSE SENSEX 35,498.44 -0.87% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 407.80 1.34% 408.35 1.54%
 More Info 
SUN PHARMA 415.10 -1.94% 414.65 -1.95%
 More Info 
TORRENT PHARMA 1,759.00 -0.99% 1,763.50 -0.69%
 More Info 
WOCKHARDT LTD. 390.25 -0.57% 389.60 -0.79%
 More Info 

BSE prices: February 18, 2019  (Close)    NSE prices: February 18, 2019  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 8,571.6 (down 0.8%). The index is down 16.8% over the last 30 days. And over the last 1 year, it has lost 8.8%.

Within the Indian Pharma sector, the top gainers were IPCA LABS (up 4.5%) and ALEMBIC PHARMA (up 1.5%). On the other hand, NATCO PHARMA (down 3.5%) and DIVIS LABORATORIES (down 2.7%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 10,641.0 (down 0.8%).




Today's Market

Sensex Ends 311 Points Lower; Consumer Durables and Energy Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended their trading session lower. Barring telecom sector and realty sector.

Related Views on News

IPCA LABS Surges by 5%; BSE HEALTHCARE Index Down 0.2% (Market Updates)

Feb 18, 2019 | Updated on Feb 18, 2019

IPCA LABS share price has surged by 5% and its current market price is Rs 815. The BSE HEALTHCARE is down by 0.2%. The top gainers in the BSE HEALTHCARE Index are IPCA LABS (up 5.1%) and THYROCARE TECHNOLOGIES (up 9.9%). The top losers are LUPIN LTD (down 0.1%) and FORTIS HEALTHCARE (down 0.1%).

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

DIVIS LABORATORIES 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Feb 18, 2019 (Close)

COMPARE COMPANY

MARKET STATS